Health IT SME development in the Baltic Sea Region: Presentation of session at Life Sciences Baltics 2018/ScanBalt Forum track
A recent survey of Health IT SME’s in the Baltic Sea Region (BSR) has pointed out better access to financing and better market access as pivotal for their development. In addition only a minority have collaboration with Public Health Authorities responsible for prevention measures and a major customer for new technologies.
The session organised by BaltCityPrevention discusses how Health IT companies, venture capital and Public Health Authorities can collaborate to overcome these short comings in the pursuit of the Baltic Sea Region as one development site and open market for Health IT products and services.
The session will have short pitches from Health IT companies, venture capital and Public Health Authorities followed by a round table discussion with focus on participatory involvement of the audience.
In advance of the session the BSR health and life science community will be invited to propose questions online. The best are selected by the session organisers and will be raised by the moderator.
More about Life Sciences Baltics 2018
Draft Programme (changes may occur)
Welcome by moderator
Thomas Frahm, Project director, Life Science Nord
BSR as one market – Top 3 to do’s from a company perspective
Didzis Glazitis, CEO, Telemedica
BSR as Health IT investment target – Should investors take an interest?
Seppo Makinen, Pathena Investments
Public Health Authorities – Need for new technologies in prevention?
Elisabet Kivimäki, Seinäjoki Business Development
Round table: How do we collaborate to make BSR a global hotspot for health it?
Sami Perälä, South Ostrobothnia Health Technology Development Centre, EPTEK
Session organising committee: Sanna Valkosala, EPTEK; Ance Balode, Telemedica; Peter Frank, ScanBalt
10 September 2021
HealthBIO 2021 | 15 September 2021